These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2659747

  • 1. A phase III study on intermittent versus weekly cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G, Casadio M, Farris A, Tononi A, Giordani S, Pannuti F.
    J Chemother; 1989 Apr; 1(2):136-9. PubMed ID: 2659747
    [Abstract] [Full Text] [Related]

  • 2. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G, Casadio M, Giuliotti C, Giordani S, Martoni A, Strocchi E, Pannuti F.
    Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346
    [Abstract] [Full Text] [Related]

  • 3. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
    Casadio M, Lelli G, Giordani S, Boltri B, Blotta A, Busutti L, Ramini R, Falcone F, Pannuti F.
    J Chemother; 1990 Jun; 2(3):199-202. PubMed ID: 2166145
    [Abstract] [Full Text] [Related]

  • 4. A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).
    Lelli G, Guaraldi M, Canova N, Casadio M, Pannuti F.
    J Chemother; 1990 Dec; 2(6):401-4. PubMed ID: 1965508
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T, Marino C, Nozzoli F, Lopes-Pegna A, Righi R, Santomaggio C, Lamanna S, Periti P.
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [Abstract] [Full Text] [Related]

  • 6. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY, Kim K, Boucher H, Bonomi P, Stewart JA, Karp DD, Blum RH.
    Cancer; 1998 Jan 15; 82(2):292-300. PubMed ID: 9445185
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR.
    Am J Clin Oncol; 1997 Oct 15; 20(5):500-4. PubMed ID: 9345336
    [Abstract] [Full Text] [Related]

  • 8. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
    Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G, Thiriaux J.
    J Clin Oncol; 1990 Sep 15; 8(9):1556-62. PubMed ID: 2167953
    [Abstract] [Full Text] [Related]

  • 9. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
    Miller AA, Herndon JE, Hollis DR, Ellerton J, Langleben A, Richards F, Green MR.
    J Clin Oncol; 1995 Aug 15; 13(8):1871-9. PubMed ID: 7636529
    [Abstract] [Full Text] [Related]

  • 10. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
    Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP, European Lung Cancer Working Party (ELCWP).
    Lung Cancer; 2000 Oct 15; 30(1):23-36. PubMed ID: 11008007
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L, Tonato M, Darwish S, Meacci ML, Corgna E, Di Costanzo F, Buzzi F, Fornari G, Santi E, Ballatori E.
    Cancer Chemother Pharmacol; 1990 Oct 15; 26(1):52-6. PubMed ID: 2157554
    [Abstract] [Full Text] [Related]

  • 12. Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
    Crinò L, Clerici M, Figoli F, Barduagni M, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F.
    Lung Cancer; 1995 Apr 15; 12 Suppl 1():S125-32. PubMed ID: 7551920
    [Abstract] [Full Text] [Related]

  • 13. A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer.
    Krook JE, Jett JR, Little C.
    Am J Clin Oncol; 1989 Apr 15; 12(2):114-7. PubMed ID: 2539716
    [Abstract] [Full Text] [Related]

  • 14. Etoposide and split-dose cisplatin in bronchogenic carcinoma.
    Lauer RC, Fisher WB, Pennington K, Ansari R, Einhorn LH, Loehrer PJ.
    Am J Clin Oncol; 1988 Dec 15; 11(6):634-5. PubMed ID: 3189229
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec 15; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS.
    Clin Lung Cancer; 2003 Jul 15; 5(1):40-5. PubMed ID: 14596703
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O, Shevrin DH, Pandya KJ, Bonomi PD.
    Am J Clin Oncol; 2000 Aug 15; 23(4):371-5. PubMed ID: 10955866
    [Abstract] [Full Text] [Related]

  • 18. A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients.
    Correale P, Cerretani D, Remondo C, Martellucci I, Marsili S, La Placa M, Sciandivasci A, Paolelli L, Pascucci A, Rossi M, Di Bisceglie M, Giorgi G, Gotti G, Francini G.
    Oncol Rep; 2006 Jul 15; 16(1):133-40. PubMed ID: 16786136
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 15; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 20. [A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)].
    Kobayashi K, Hino M, Kurane S, Yano T, Niitani H, Yamano Y, Hasegawa K, Tuboi E.
    Gan To Kagaku Ryoho; 1989 Feb 15; 16(2):207-12. PubMed ID: 2537605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.